These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 31288785)

  • 21. Initial multicentre experience of
    Siriwardana A; Thompson J; van Leeuwen PJ; Doig S; Kalsbeek A; Emmett L; Delprado W; Wong D; Samaratunga H; Haynes AM; Coughlin G; Stricker P
    BJU Int; 2017 Nov; 120(5):673-681. PubMed ID: 28548372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer.
    Meijer D; Luiting HB; van Leeuwen PJ; Remmers S; Jansen BHE; Bodar YJL; Witteveen T; Schaake EE; van der Poel HG; Wondergem M; Busstra MB; Nieuwenhuijzen JA; Meijnen P; Brabander T; van Moorselaar RJA; Hendrikse NH; Oprea-Lager DE; Roobol MJ; Vis AN
    J Urol; 2021 Apr; 205(4):1100-1109. PubMed ID: 33207138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
    Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
    Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection.
    Burkhard FC; Bader P; Schneider E; Markwalder R; Studer UE
    Eur Urol; 2002 Aug; 42(2):84-90; discussion 90-2. PubMed ID: 12160577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes.
    Linxweiler J; Saar M; Al-Kailani Z; Janssen M; Ezziddin S; Stöckle M; Siemer S; Ohlmann CH
    Surg Oncol; 2018 Jun; 27(2):138-145. PubMed ID: 29937163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer.
    Meijer D; de Barros HA; van Leeuwen PJ; Bodar YJL; van der Poel HG; Donswijk ML; Hendrikse NH; van Moorselaar RJA; Nieuwenhuijzen JA; Oprea-Lager DE; Vis AN
    J Urol; 2021 Jun; 205(6):1655-1662. PubMed ID: 33530746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer volume of lymph node metastasis predicts progression in prostate cancer.
    Cheng L; Bergstralh EJ; Cheville JC; Slezak J; Corica FA; Zincke H; Blute ML; Bostwick DG
    Am J Surg Pathol; 1998 Dec; 22(12):1491-500. PubMed ID: 9850175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease.
    Spahn M; Briganti A; Capitanio U; Kneitz B; Gontero P; Karnes JR; Schubert M; Montorsi F; Scholz CJ; Bader P; van Poppel H; Joniau S;
    J Urol; 2012 Jul; 188(1):84-90. PubMed ID: 22578727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation.
    Sooriakumaran P; Karnes J; Stief C; Copsey B; Montorsi F; Hammerer P; Beyer B; Moschini M; Gratzke C; Steuber T; Suardi N; Briganti A; Manka L; Nyberg T; Dutton SJ; Wiklund P; Graefen M
    Eur Urol; 2016 May; 69(5):788-94. PubMed ID: 26038098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robot-Assisted Extended Pelvic Lymph Nodes Dissection for Prostate Cancer: Personal Surgical Technique and Outcomes.
    Porpiglia F; De Luca S; Bertolo R; Passera R; Mele F; Manfredi M; Amparore D; Morra I; Fiori C
    Int Braz J Urol; 2015; 41(6):1209-12019. PubMed ID: 26742982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four-point Peritoneal Flap Fixation in Preventing Lymphocele Formation Following Radical Prostatectomy.
    Stolzenburg JU; Arthanareeswaran VKA; Dietel A; Franz T; Liatsikos E; Kyriazis I; Ganzer R; Yaney K; Do HM
    Eur Urol Oncol; 2018 Oct; 1(5):443-448. PubMed ID: 31158086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radical perineal prostatectomy without lymphadenectomy. Patients with cT1 + 2, G1 +2, PSA < or = 10 ng/ml prostate carcinoma].
    Jakse G; Brehmer B; Wolff JM; Aretz R; Handt S
    Urologe A; 1999 Mar; 38(2):143-9. PubMed ID: 10231935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database.
    Schiavina R; Bianchi L; Borghesi M; Briganti A; Brunocilla E; Carini M; Terrone C; Mottrie A; Dente D; Gacci M; Gontero P; Gurioli A; Imbimbo C; La Manna G; Marchioro G; Milanese G; Mirone V; Montorsi F; Morgia G; Munegato S; Novara G; Panarello D; Porreca A; Russo GI; Serni S; Simonato A; Urzì D; Verze P; Volpe A; Martorana G
    Int J Urol; 2016 Dec; 23(12):1000-1008. PubMed ID: 27620370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node-positive prostate cancer after robotic prostatectomy and extended pelvic lymphadenectomy.
    Chenam A; Parihar JS; Ruel N; Pal S; Avila Y; Yamzon J; Lau C; Yuh B
    J Robot Surg; 2018 Sep; 12(3):425-431. PubMed ID: 28905289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage Pelvic Lymph Node Dissection after Radical Prostatectomy for Biochemical and Lymph Node Recurrence.
    Peeters C; Ponette D; van Poppel H
    Urol Int; 2017; 98(3):367-369. PubMed ID: 25228162
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Herlemann A; Wenter V; Kretschmer A; Thierfelder KM; Bartenstein P; Faber C; Gildehaus FJ; Stief CG; Gratzke C; Fendler WP
    Eur Urol; 2016 Oct; 70(4):553-557. PubMed ID: 26810345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer.
    Kava BR; Dalbagni G; Conlon KC; Russo P
    Ann Surg Oncol; 1998 Mar; 5(2):173-80. PubMed ID: 9527271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.